An OIG exclusion notice or a DOJ subpoena naming you personally, not only your practice or company, often traces to a single legal theory: the Responsible Corporate Officer doctrine. Under this doctrine, sometimes called the Park doctrine after the Supreme Court case that defined it, an executive can face criminal liability for a company's regulatory violation without personal knowledge of the wrongdoing, based solely on the authority the position carries to prevent or correct it. For a physician who also holds an ownership stake, a medical director title, or a compliance role in a pharmacy, laboratory, or device company, that authority is often assumed, whether or not it was ever exercised. The exposure reaches further than most executives expect.
What the Responsible Corporate Officer Doctrine Requires
The doctrine traces to two Supreme Court cases interpreting the Federal Food, Drug, and Cosmetic Act: United States v. Dotterweich, 320 U.S. 277 (1943), and United States v. Park, 421 U.S. 658 (1975). In Park, the Court held that a corporate officer with the authority to prevent or correct a violation carries an affirmative duty to do so, and can be convicted of a misdemeanor for failing to act even without evidence of personal awareness or intent. The elements are narrow: a position of real authority, the practical ability to prevent or correct the violation, and a failure to exercise that authority. Negligence in fulfilling the duty is sufficient. Knowledge and intent are not elements the government has to prove.
How It Reaches Healthcare Executives
Prosecutors have applied the doctrine most visibly against pharmaceutical and device executives, where a company-level violation, often built on off-label promotion, misbranding, or a kickback scheme, becomes the basis for an individual misdemeanor charge. The clearest example is the 2007 prosecution of three Purdue Frederick executives, including its president, who pleaded guilty to misdemeanor misbranding under the doctrine over the marketing of OxyContin. Prosecutors did not allege that any of the three personally knew of the underlying misconduct; their liability rested on their corporate positions alone. A parallel civil or administrative track often runs alongside the criminal exposure, opened by a grand jury subpoena or a civil investigative demand tied to a suspected Anti-Kickback Statute or Stark Law violation, naming the same executives a later doctrine-based charge would target, as Parallel Proceedings: Managing Civil, Criminal, and Administrative Tracks at Once explains.
OIG's Permissive Exclusion Authority
A misdemeanor conviction under the doctrine carries a second, often more consequential exposure: exclusion from Medicare, Medicaid, and every other federal healthcare program under OIG's permissive exclusion authority, codified at 42 U.S.C. § 1320a-7(b)(15). That provision lets OIG exclude an officer or controlling individual of an entity already convicted or excluded, for a period tied to the entity's own exclusion. The Purdue Frederick executives tested this authority: OIG sought to exclude each of them for twenty years, later reduced, and they challenged it in Friedman v. Sebelius, 686 F.3d 813 (D.C. Cir. 2012). The D.C. Circuit upheld OIG's authority to exclude officers convicted under the doctrine, while sending the exclusion length back for reconsideration. The lesson survives that remand: a misdemeanor plea resolving criminal exposure can open a separate exclusion proceeding with its own stakes, described in OIG Exclusion: Scope, Screening, and Collateral Damage.
Reducing Exposure Through Documented Oversight
The doctrine rewards positions with defined, exercised authority over undefined or purely titular ones. A compliance posture that mitigates exposure starts with documentation: escalation memos, corrective action plans, and committee minutes showing an issue was identified, assigned, and tracked to resolution. Delegation matters only when it carries actual authority and resources; a delegate with the title but not the budget to act does not relieve the officer who assigned the task. Active engagement with a written compliance program, including periodic review of audit findings, gives an executive a record showing the authority structure functioned as designed, separating reasonable reliance on that system from an unsupported claim that someone else was responsible.
Under the Responsible Corporate Officer doctrine, criminal liability turns on your authority to prevent a violation, not on whether you knew it occurred.
Why Early Legal Counsel Is Critical
It is critical that physicians and healthcare executives promptly retain experienced healthcare defense counsel upon receiving a subpoena, audit notice, investigative request, or other government inquiry. Early legal intervention can protect the executive's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the executive's behalf. Delaying legal representation can significantly affect the outcome of a matter.
How Health Law Alliance Can Help
Health Law Alliance has handled 5,000+ matters and overseen 2,000+ audits across healthcare regulatory and criminal defense over 25+ years, including matters where an executive's title, not personal conduct, became the government's theory of liability. If you or an executive at your practice or company received a target letter, a subpoena, or an OIG notice raising Responsible Corporate Officer exposure, contact Health Law Alliance's healthcare fraud defense attorneys for a free, confidential consultation.
